• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合高压氧疗法与优特克单抗治疗重度化脓性汗腺炎

Combination hyperbaric oxygen therapy and ustekinumab for severe hidradenitis suppurativa.

作者信息

Provini Lauren E, Stellar Judith J, Stetzer Molly N, Nguyen Phuong D, Jen Melinda

机构信息

Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Wound and Ostomy Program, Department of Nursing, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

出版信息

Pediatr Dermatol. 2019 May;36(3):381-383. doi: 10.1111/pde.13775. Epub 2019 Feb 25.

DOI:10.1111/pde.13775
PMID:30805965
Abstract

Hidradenitis suppurativa is a painful chronic inflammatory skin condition characterized by inflammatory nodules that can lead to sinus tracts and scarring. Numerous treatments have been reported, though none have reliable efficacy. Antiinflammatory agents, such as tumor necrosis factor-alpha inhibitors and interleukin inhibitors, have been used as medical therapy for refractory cases. We describe here a case of severe hidradenitis suppurativa in a pediatric patient successfully treated with a combination of high-dose ustekinumab and hyperbaric oxygen therapy.

摘要

化脓性汗腺炎是一种疼痛的慢性炎症性皮肤病,其特征为炎症性结节,可导致窦道和瘢痕形成。虽然已有多种治疗方法的报道,但尚无一种具有可靠疗效。抗炎药,如肿瘤坏死因子-α抑制剂和白细胞介素抑制剂,已被用于难治性病例的药物治疗。我们在此描述一例严重化脓性汗腺炎的儿科患者,通过高剂量优特克单抗和高压氧治疗联合成功治愈。

相似文献

1
Combination hyperbaric oxygen therapy and ustekinumab for severe hidradenitis suppurativa.联合高压氧疗法与优特克单抗治疗重度化脓性汗腺炎
Pediatr Dermatol. 2019 May;36(3):381-383. doi: 10.1111/pde.13775. Epub 2019 Feb 25.
2
Recognition, diagnosis, and treatment of hidradenitis suppurativa.化脓性汗腺炎的识别、诊断及治疗
JAAPA. 2019 Oct;32(10):36-42. doi: 10.1097/01.JAA.0000578768.62051.13.
3
Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.阿达木单抗和优特克单抗联合治疗克罗恩病合并化脓性汗腺炎取得成功。
Dermatol Online J. 2019 Sep 15;25(9):13030/qt0hw2w4nr.
4
High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa.高剂量、高频度乌司奴单抗治疗重度化脓性汗腺炎患者。
Br J Dermatol. 2022 Sep;187(3):417-419. doi: 10.1111/bjd.21066. Epub 2022 May 18.
5
Ustekinumab for hidradenitis suppurativa: a case report.
Actas Dermosifiliogr. 2014 Sep;105(7):720-2. doi: 10.1016/j.ad.2013.09.011. Epub 2013 Dec 3.
6
Ustekinumab treatment for hidradenitis suppurativa.乌司奴单抗治疗化脓性汗腺炎。
J Dermatol. 2019 Dec;46(12):1215-1218. doi: 10.1111/1346-8138.15122. Epub 2019 Oct 22.
7
Outcomes After Combined Radical Resection and Targeted Biologic Therapy for the Management of Recalcitrant Hidradenitis Suppurativa.联合根治性切除与靶向生物治疗顽固性化脓性汗腺炎后的疗效
Ann Plast Surg. 2016 Aug;77(2):217-22. doi: 10.1097/SAP.0000000000000584.
8
Hyperbaric oxygen therapy (HBOT )can improve the effectiveness of adalimumab in hidradenitis suppurativa.高压氧疗法(HBOT)可提高阿达木单抗治疗化脓性汗腺炎的疗效。
G Ital Dermatol Venereol. 2020 Apr;155(2):234-235. doi: 10.23736/S0392-0488.18.05913-8. Epub 2018 Apr 19.
9
Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.英夫利昔单抗治疗克罗恩病患者的化脓性汗腺炎
J Dermatolog Treat. 2005 Feb;16(1):58-61. doi: 10.1080/09546630410024547.
10
Effectiveness of ustekinumab for moderate-to-severe hidradenitis suppurativa: a case series.乌司奴单抗治疗中重度化脓性汗腺炎的有效性:病例系列研究
J Dermatolog Treat. 2022 Mar;33(2):1159-1162. doi: 10.1080/09546634.2020.1776208. Epub 2020 Jun 11.

引用本文的文献

1
A Review of Hidradenitis Suppurativa in Special Populations: Considerations in Children, Pregnant and Breastfeeding Women, and the Elderly.特殊人群中的化脓性汗腺炎综述:儿童、孕妇和哺乳期妇女以及老年人的注意事项
Dermatol Ther (Heidelb). 2024 Sep;14(9):2407-2425. doi: 10.1007/s13555-024-01249-2. Epub 2024 Sep 4.
2
Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment.高压氧通过调节肿瘤微环境促进免疫治疗的进展。
Front Oncol. 2023 Sep 15;13:1200619. doi: 10.3389/fonc.2023.1200619. eCollection 2023.
3
Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options.
儿童和青少年化脓性汗腺炎:药物治疗选择的最新进展。
Paediatr Drugs. 2023 Nov;25(6):659-676. doi: 10.1007/s40272-023-00595-6. Epub 2023 Oct 2.
4
Overexpression of hypoxia-inducible factor-1α in hidradenitis suppurativa: the link between deviated immunity and metabolism.在化脓性汗腺炎中缺氧诱导因子-1α 的过表达:偏离的免疫与代谢之间的联系。
Arch Dermatol Res. 2023 Sep;315(7):2107-2118. doi: 10.1007/s00403-023-02594-6. Epub 2023 Mar 24.
5
Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review.生物制剂在化脓性汗腺炎患儿中的应用:系统评价。
J Cutan Med Surg. 2022 Mar-Apr;26(2):176-180. doi: 10.1177/12034754211049711. Epub 2021 Sep 29.
6
Insights into the Pathogenesis of HS and Therapeutical Approaches.化脓性汗腺炎发病机制及治疗方法的见解。
Biomedicines. 2021 Sep 6;9(9):1168. doi: 10.3390/biomedicines9091168.
7
[Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update].[化脓性汗腺炎/反向性痤疮——手术选择、重建及与药物治疗的联合应用——最新进展]
Hautarzt. 2021 Aug;72(8):692-699. doi: 10.1007/s00105-021-04864-8. Epub 2021 Jul 6.
8
Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice.化脓性汗腺炎的医学和手术治疗:国际治疗指南综述及在普通皮肤科实践中的应用。
Dermatology. 2020;236(5):393-412. doi: 10.1159/000507323. Epub 2020 May 14.